WebmedCentral Editor
View all WebmedCentral Editors
 
No Image

Dr. Esther Una Cidon

Doctor Specialist in Medical Oncology
Oncology Department, Royal Bournemouth Hospital
Castle Lane East
 

Brief Biography:


Occupation: Oncologist, Educator
Born: Zamora, Spain, October 19, 1975
Education:
Degree in Medicine and Surgery, University of Salamanca, MD (1999)
Training to become Medical Oncologist at the Central University Hospital of Oviedo, 2000-2004
Master's Degree in Palliative Medicine, University of Valladolid, 2004-2006
PhD, University of Valladolid (Cost-effectiveness evaluation of two strategies of colon cancer followup). With the highest qualification, 2009
Politics Sciences Student, Spanish University "at distance" Education
Master's Degree in Molecular Oncology, at the National Center of Cancer Research, Madrid, 2008-2010.

Master's Degree in Clinical Management and Costs in Healthcare, 2010-2012.

Master's Degree in Management of Oncology Services, 2013.

Specialization in bioethics and biolaw, 2015-2016

Career:
Specialist Registrar in Medical Oncology at the Central University Hospital Oviedo, 2000-2004

Consultant Medical Oncologist, Clinical University Hospital of Valladolid (Spain) 2004-2012

Secretary Colorectal Tumours Committee 2008-2012

Member of the Histology /Tumours and Mortality Committee 2010-2012

Associated Professor of Oncology and Palliative Care at the School of Medicine, University Valladolid, 2007-2012.


Career Related:
Speaker in fields; board member Health Care Adv., Canada, 2009-; member Colorectal Tumours Working Group of Castilla-Leon, 2010-2012; associate editor Global Journal Surgery Oncology, Journal US China Sci. & Medicine; member of the editorial board of World Journal of Hepatology (oncology section) 2013-, Cancers Review, etc; editor-in-chief The Challenge of Colorectal Cancer: A Review Book;, Senior editor of the Journal of Solid Tumours; associate editor of WJGNET journal, editor of Pharma-utility; editor in chief of The easy book of cancer pharmacology with NovaPublishers (published in 2016)

  1. Member of the Scientific Advisory Board of the BIT’s Annual World Cancer Congress 2012, 2013, 2014, 2015, 2016, 2017. 
  2. Member of the Advisory Board Members of the BIT’s International Congress of Gynaecology and Obstetrics (section Oncology); 2012, 2013. China.   


Creative Works:
Contributor articles to professional journals and books

Awards:
Recipient National Profesor Barea awards, Clinical Management & Health Costs, 2009
Recipient National Profesor Barea awards, Clinical Management & Health Costs, 2010
Woman of the year 2011 in Medicine and Healthcare (elected by the American Biographical Institute, USA)
Medal of the Order of International Ambassadors in Sciences, American Biographical Institute, USA.
Elected as part of the book Who´s who in the World 2010, 2011, 2012, 2013, 2014, Pearl Anniversary Edition, 2015, 2016. 
Elected as one of the 1000 Great Minds of the 21st century
Elected as one of the 2000 Outstanding Intellectuals of the 21st century
Elected as part of the book Who´s who in Medicine and Healthcare 2011, 2012.

Selected as one of the Top 100 Health Professionals in the arena of Medical Oncology 2011-2012, Medal of Achievement 2011. International Biographical Centre (IBC Cambridge). 

Recipient of the GoldMedal for Spain in recognition of global achievements and contributions in Medicine and Cancer Care and Research. September 2011. American Biographical Institute (ABI North Caroline).

Medal of Achievement 2011. International Biographical Centre (IBC Cambridge). 



Memberships:

Royal College of Physicians (RCP)

Spanish Society of Medical Oncology (SEOM).

American Society of Clinical Oncology (ASCO).

Charter member of Society for Traslational Oncology (STO).

Member of the Order of International Ambassadors in Sciences. Since March 2011.

European Association for Cancer Research (EACR).

International Society for Gastrointestinal Oncology (ISGIO).

International Who´s Who Historical Society.

International Who’s Who of Professional Educators.

Association Oncology Castilla-Leon

European Society of Medica Oncology (ESMO)
Address:
Office: Oncology Department, Royal Bournemouth Hospital, Castle Lane East, Bournemouth BH7 7DW (United Kingdom)

 

 

 

Academic positions:


Medical Oncologist: Oncology Department, Clinical University Hospital of Valladolid (Spain). 2004-2012.

                                     Oncology Department, Royal Bournemouth Hospital (United Kingdom). 2012-...


Professor of Oncology and Palliative Medicine, Faculty of Medicine of Valladolid (Spain). 2007-2012.

 

Research interests:


Gastrointestinal Tumours
Breast and gynecological Tumours
Health costs and clinical management

 

Any other information:


PUBLICATIONS (last 5 years):

E. Una Cidon, (2016). "The easy book of cancer pharmacology". NovaPublishers editions. ISBN: 978-1-63485-043-8 

E. Una Cidon, P. Alonso, B. Masters (2016). Markers of response to antiangiogenic therapies in colorectal cancer: Where are we now and what should be next?. Clinical Medicine Insights: Oncology

E. Una Cidon (2016). Resectable cholangiocarcinoma: reviewing the role of adjuvant strategies.

E Una Cidon, J Bennett, S Needham, J Hack (Sep. 2015) ‘Prompt diagnosis of abdominal wall recurrences from colorectal cancer requires high index of suspicion’, Int J Adv in Case Rep 2(18) e-ISSN-2349-8005.

E Una Cidon, P Alonso (Oct. 2014) ‘Ocular toxicities in cancer therapy: still overlooked’, Current Cancer Therapy Reviews, doi:10.2174/157339471001140815152249

E Una Cidon, M Varga, T Geldart, P Alonso (Dec 2014) Widespread use of pemetrexed: Has it turned it into a new drug? Chinese Clinical Oncology, 3(4)

E Una Cidon, T Hickish (May. 2014) ‘Stem cells in colon cancer’ in Grande, E. and Anton Aparicio, L. (Eds), Stem Cells in Cancer: should we believe or not?. Springer, ISBN 978-94-017-8753-6.

B Masters, T Hickish, E Una Cidon (Jun. 2014) ‘A midline for oxaliplatin infusion: the myth of safety devices’, BMJ Case Rep, doi:10.1136/bcr-2014-204360. 

E Una Cidon (Feb. 2014) ‘A rare cause of melanonychia’, WebmedCentral Cancer, 5.2:WMC0045

E Una Cidon (Feb. 2014) ‘An oncology nursing intervention to reduce adverse drug events in ambulatory cancer patients’, WebmedCentral Cancer, 5.2:WMC004535.  

E Una Cidon, M Miller, T Hickish, L Purandare (Jan. 2014). ‘Estudio piloto de aplicacion del teletriage como estrategia de aproximacion a la consulta oncologica urgente’, Gestion y evaluacion de costes sanitarios 1-12.

Uña E, Ellis S, Inam Y, Olusola A, Zarif S, Geldart T. Molecular Targeted Agents for Gastric Cancer: A Step Forward Towards Personalized Therapy. Cancers 2013, 5(1), 64-91; doi:10.3390/cancers5010064

Una Cidon E, Alonso P. Pilot Study of Insomnia Prevalence in Cancer Survivors . WebmedCentral CANCER 2013;4(3):WMC004161

Una Cidon E. Cost-Effectiveness Studies Applied to the Screening Of Colorectal Cancer . WebmedCentral ECONOMICS OF MEDICINE 2013;4(2):WMC004014

Uña E, Cuadrillero F, Hijas M, López-Lara F. Pilot Study of Satisfaction in Oncology Nursing Care: An Indirect Predictor of Quality of Care. International Journal of Health Care Quality Assurance 2012;25(2):106-117. PMID:21151842.

Uña E. Intraventricular metastases from small cell carcinoma of the lung.BMJ Case Rep. 2012 May 8;2012. pii: bcr1220115440. doi: 10.1136/bcr.12.2011.5440.PMID:22605865[PubMed - in process]

Uña E. Early appearance of osteonecrosis of the jaw after zoledronic acid in a patient with a long history of taking oral bisphosphonates.BMJ Case Rep. 2012 Mar 27;2012. pii: bcr1120115244. doi: 10.1136/bcr.11.2011.5244. PMID:22605820[PubMed - in process]

Uña E, Centeno RG, Lagarto EG, Peral JI. Her-2 evaluation in a specific gastric cancer population with the highest rate of mortality in Spain. J Oncol. 2011:391564. Epub 2011 Oct 27. PMID:22131990 [PubMed - in process]

Cidón EU, Perea C, López-Lara F. Life after breast cancer: dealing with lymphoedema.Clin Med Insights Oncol. 2011 Feb 7;5:9-14.PMID:21339859.

Cidón EU. What is the optimal treatment for metastatic colorectal cancer? Controversial Points. J Cancer Sci Ther S4:003. Doi:10.4172/1948-5956. S4-003.

Uña E. Atypical presentation of acute neurotoxicity secondary to oxaliplatin. J Oncol Pharm Pract. 2010 Dec;16(4):280-2. Epub 2009 Dec 16.PMID:20015928.

Cidón EU. A Different Variable to Stratify Risk in Resected Gastric Cancer. Ann Surg Oncol, 2010;17(2):657-658. PMID:19882187.

Uña E. Sexual problems after breast cancer: the underreported symptoms. Gynecol Oncol 2010;116:147. PMID:19861226.

Uña Cidón E. Implementation of an effective communication model between levels of health as the first measure to save costs in oncology. (article in Spanish). Journal of Clinical Management and Cost Evaluation, 8º edition, Signo Foundation, Barea’s Professor Awards, May 2010.

Uña E, López-Lara F. Pilot study of a clinical pathway implementation in rectal cancer. Clin Med Insights Oncol 2010,12(4);111-115. PMID:21151842.

Uña E, Salvador A, Fernández M, Cuadrillero F, Hijas M, López-Lara F. Implementation of a model of effective management of time in an outpatient Oncology Unit (article in Spanish). Journal of Clinical Management and Cost Evaluation, 7º edition, Signo Foundation, Barea’s Professor Awards, May 2009.

Uña E. Gastric cancer: predictors of recurrence when lymph-node dissection is inadequate. World J Surg Oncol 2009;7:69. PMID:19761613.

Uña E, Trueba J, Montes JM. Unexplained liver laceration after metastasis radiofrequency ablation. World J Gastroenterol 2009;15(40):5103-5105. PMCID: PMC2768892.

Uña E, Gandía F, Duque JL. Tongue paralysis after orotracheal intubation in a patient with primary mediastinal tumor: a case report. Cases J 2009;2: 9301-9304. PMID:20062625.

Cidón EU. A Commentary on “Risk Factors for Renal Cell Cancer in a Japanese Population” Clinical Medicine Oncology 2009;3:87-90. PMID:20689614.

Uña E, Cuadrillero F, López-Lara F. Drug extravasation: a dreaded complication. BMJ Case Rep. 2009;2009 pii:bcr09.2008.0887. Epub 2009 Apr 14. PMID:21686582.

Uña E, García-Tejeiro M, Álvarez M. Primary Peritoneal Malignant Mixed Müllerian Tumor in a Young Woman: Achieving the Best Clinical Benefit. Case Rep Oncol 2009;2:162-167. PMID:20737031.

Cidón EU, Cuenca IJ. Gastric Adenocarcinoma: Is Computed Tomography (CT) Useful in Preoperative Staging?. Clinical Medicine Oncology 2009; 3:91-97.PMID:20689615.

Uña E. Clinical benefit and safety of gastric cancer treatment. Journal of Gastric Cancer (article in Spanish) 2008;3:20-25. ISSN: 2013-2441.

Uña Cidón AB, de la Torre I, Uña Cidón E. El estándar DICOM y su nivel de implantación en Europa. Revista eSalud.com 2011, 7(27).

Una Cidón E , Contaldo An , Cocozza Gi . A Silent Chemotherapy Extravasation as the Unexpected Enemy: A Case Report . WebmedCentral ONCOLOGY 2011;2(9):WMC002261.

Cidón EU. Giant macroglossia in head and neck cancer survivor: the unsolved issue. International Journal of Case Reports and Images 2011;2(12):11-14.
27.Uña Cidón E. Steroids, cancer and vertebral fractures: a dreaded combination. J Oncol Pharm Pract. 2011Sep;17(3):279-81. Epub 2010 Apr 15. PMID:20395352.[PubMed - indexed for MEDLINE]

Cidón EU, R Bustamante. Gastric Cancer: Tumor Markers as Predictive Factors for Preoperative Staging. J Gastrointest Canc 2011,42(3):127-130.PMID:20499209.

Cidón EU. The challenge of metastatic colorectal cancer. Clin Med Insights Oncol 2010,18(4):55-60.

Cidón EU. Cutaneous metastases in 42 patients with cancer. Indian J Dermatol Venereol Leprol 2010,76(4):409-412. PMID:20657126.

Cidón EU. Gastric cancer and the search for a good prognostic classification: a challenge. Clin Exp Gastroenterol. 2010;3:113-6. Epub 2010 Jul 22.PMID:21694854.

Uña E. Nutritional Status After Total Gastrectomy for Gastric Cancer World Journal of Oncology 2010;12: 87-90.

Hortelano E, Perea C, Uña E, Cebayos A, Diezhandino P, González M. Parkinsonism secondary to metastatic lesions within the central nervous system: a case report. J Med Case Rep 2010 Jul 21;4:218-221.

Uña E. Capecitabine associated hand-foot syndrome: A review Clinical Medicine Reviews in Oncology 2010;2: 60-69.

Losa R, Fra J, López Pousa A, Sierra M, Goitia A, Uña E, Nadal R, Del Muro JG, Gión M, Maurel J, Escudero P, Esteban E, Buesa JM. Phase II Clinical Trial of Dacarbazine and prologed infusión of Gemcitabine in patients with advanced soft tissue sarcomas. Cancer Chem Pharmacol, 2007;59(2):251-259. PMID:16736150.

BOOK CHAPTERS (last 5 years)

 

E Una Cidon (2013). ‘Appetite stimulants in cancer patients: still a challenge’in Bienertova, J. (Ed), Appetite regulation, use of stimulants and cultural and biological influences. Novapublishers, ISBN: 978-1-63117-241-0

E Una Cidon, T Hickish (May. 2014) ‘Stem cells in colon cancer’ in Grande, E. and Anton Aparicio, L. (Eds), Stem Cells in Cancer: should we believe or not?. Springer, ISBN 978-94-017-8753-6.

Buesa JM, Fra J, Uña E. Soft Tissue Sarcomas. Chapter XXI. Protocols in Oncology, 3º edition. M-28695-2005. Glaxo Smith Kline. (Spanish Book).
Nuñez H, Uña E, Herreros J, Abril C, Romero A. Chapter 4th : Local management of primary colorectal cancer: focus on surgery. Book: Uña Cidón, Esther: The challenge of Colorectal cancer: a review book, Kerala (India), Research Signpost, 2011, pp 75-101. ISBN 978-81-308-0460-6.
Uña E. Chapter 14th: Issues in colorectal cancer survivors. Book: Uña Cidón, Esther: The challenge of Colorectal cancer: a review book, Kerala (India), Research Signpost, 2011, pp 331-351. ISBN 978-81-308-0460-6.
Uña E. Chapter 11th: The relevance of nutrition before and after gastrectomy for gastric cancer patients. Book: D’Annibale A, Pende V, Monsellato I. Book Gastric Cancer: From staging to surgical treatment. Procedures, complications and oncological results, Italy, Nova Publishers, 2012, ISBN 978-1-62081-294-5.
Uña E. Chapter 13th: Neuropathy secondary to chemotherapy: a real issue for cancer survivors. Book: Seyed Mansoor Rayegani: Basic Principles of peripheral nerve disorders, Croatia, Intech, 2012, pp 215-252. ISBN 978-953-51-0407-0.
Uña E, Hickish T. Stem Cells in Colon Cancer. Book: Stem cells in cancer: should we believe or not. Elsevier Editorial.

Una Cidon, E. Nivolumab. The easy book of cancer pharmacology. NovaPublishers (pending publication 2016)

Una Cidon, E. Irinotecan. The easy book of cancer pharmacology. NovaPublishers (pending publication 2016)

Una Cidon, E. Pembrolizumab. The easy book of cancer pharmacology. NovaPublishers (pending publication 2016)

Una Cidon, E. Sorafenib. The easy book of cancer pharmacology. NovaPublishers (pending publication 2016)

Una Cidon, E. Nindetanib. The easy book of cancer pharmacology. NovaPublishers (pending publication 2016)

Una Cidon, E. Paclitaxel. The easy book of cancer pharmacology. NovaPublishers (pending publication 2016)

Una Cidon, E. Cabazitaxel. The easy book of cancer pharmacology. NovaPublishers (pending publication 2016)

Coauthor of Docetaxel. The easy book of cancer pharmacology. NovaPublishers (pending publication 2016)

 

BOOKS (last 5 years)

Una Cidon, Esther (editor in chief): The easy book of cancer pharmacology. NovaPublishers (pending publication 2016)

Uña Cidón, Esther (editor in chief): The challenge of Colorectal cancer: a review book, Kerala (India), Research Signpost, 2011, pp 331-351. ISBN 978-81-308-0460-6.
Uña Cidón, Esther: Cost-effectiveness analysis of colon cancer follow-up, Saarbrücken (Germany), Editorial Académica Española, 2011, 106 pages. ISBN 978-3-8465-7159-0.

REVIEWER OF:

 

MEDICAL JOURNALS
Journal of Oncology Pharmacy Practice, SAGE journals.

European Journal of Surgical Oncology, Elsevier.

Annals of Surgical Oncology, Springer.

Clinical Medicine Insights in Oncology, Libertas Academica.

Biomarkers in Cancer, Libertas Academica.

Cancer Growth and Metastasis, Libertas Academica.

Clinical Medicine Reviews in Oncology, Libertas Academica.

International Journal of Gastrointestinal Cancer, Springer.

Journal of Medical Case Reports, Springer.

British Medical Journal Case Reports, BMJ Publishing Group.

 

CLINICAL MANAGEMENT AND HEALTH COSTS
International Journal of health care quality assurance, Emerald Publishing Group.

Clinico-Economics and Outcomes Research, Dove Press.

RESEARCH GRANTS (last 5 years)

 

“HER-2 evaluation in a population with high risk of gastric cancer”. € 16.000. Granted by The Department of Health of Castilla y León (Spain). 2010-2012.

“Pilot study of a clinical pathway implementation in rectal cancer: effectiveness, efficiency and satisfaction”. € 6.000. Granted by The Department of Health of Castilla y León (Spain). 2008-2010.

 

SPONSORED RESEARCH PROJECTS (last 5 years):

 

Observational cross-sectional study to establish the link between age/performance status with the administration of doublet or triplet chemotherapy with capecitabine in advanced gastric cancer patients (Xegatran). ML 25029. Sponsor Roche Farma S.A. Principal Investigator. 2009-2010.
Maintenance therapy for Colorectal Cancer with bevacizumab: AVAMAX. Sponsor Roche Farma S.A. Collaborative Investigator 2010.
Prospective observational epidemiological study of prognostic factors associated with cancer outcomes in advanced non-small cell lung cancer patients candidates to second line therapy. Sponsor Roche Farma S.A. Collaborative Investigator. 2009.
Phase II clinical trial: Docetaxel, cisplatin and bevacizumab as front-line treatment in locally advanced or metastatic non-small cell lung cancer. Sponsor Roche Farma S.A. Principal Investigator 2008-2009.


CLINICAL TRIALS (2012-2013): Subinvestigator

BILCAP trial (cholangiocarcinoma; adjuvant)
VIPtrial (pancreatic cancer; metastatic)
SAFEHER (breast cancer; adjuvant)
SCOT trial (colon cancer; adjuvant)
ENCHANT trial (breast cancer)

 

Principal Investigator (2016) IMPALA Trial, Add Aspirin

 

COMMUNICATIONS TO CONGRESSES AND CONFERENCES

 

ASCO CONGRESS

 

Uña E. 2012 (January) HER2 evaluation in a specific gastric cancer population with the highest rate of mortality in Spain. Poster presented at Gastrointestinal Cancers Symposium (Session Cancers of the Esophagus and Stomach). J Clin Oncol 30, 2012 (suppl 4; abstr 60).
Uña E, Alonso P, Perea C. 2011 (June). Rectal cancer: The relevance of the interval between chemoradiation (CT) and surgery. Colorectal Cancer. Book Communication ASCO Annual Meeting. J Clin Oncol 29, 2011 (suppl; abstr e14029).
López-Lara F, Uña E. 2010 (June) Institutional implementation of a clinical pathway in rectal cancer: the advantages of standardization of protocols. Health Services Research. Book Communication ASCO Annual Meeting. J Clin Oncol 28, 2010 (suppl; abstr e16536).
Uña E. 2010 (September). Early breast cancer and breast-conserving therapy: Predictors of residual disease in the reexcision. Poster presented at Breast Cancer Symposium (Local / Regional Therapy). Poster 158.
Uña E. 2010 (June). Relevance of screening on the colorectal cancer population. Colorectal Cancer. Book Communication ASCO Annual Meeting. J Clin Oncol 28, 2010 (suppl; abstr e14119).
Uña E, López-Lara F. 2009 (January). Cost and Effectiveness of Follow-up examinations in patients with Colon Cancer (CC) resected for cure. Poster presented at Gastrointestinal Cancers Symposium (Prevention, diagnosis and screening). Poster 314.
Uña E. 2009 (September). Sexual problems after breast cancer diagnosis. Book communication at Breast Cancer Symposium (Treatment). Poster 354.
Uña E, De la Torre A. 2008 (June). A new risk variable to predict prognosis in gastric cancer. Gastrointestinal (Non-colorectal) Cancers. Book Communication ASCO Annual Meeting. J Clin Oncol 26, 2008 (suppl; abstr e15532).

WORLD CONGRESS ON GASTROINTESTINAL CANCER / ESMO CONGRESS

 

03/07/2015      First cycle dose calculation in obese patients with colorectal cancers. Poster, 17th World Congress on Gastrointestinal Cancer, Barcelona, Spain

 

03/07/2015      Ocular toxicities after oxaliplatin: a more frequent toxicity than expected. Poster, 17th World Congress on Gastrointestinal Cancer, Barcelona, Spain

02/07/2015      The impact of comorbidities in deciding the first dose of chemotherapy in gastrointestinal tumours. Poster, 17th World Congress on Gastrointestinal Cancer, Barcelona, Spain

27/6/2014        Cetuximab as monotherapy in elderly patients with metastatic colorectal cancer. Poster, 16th World Congress on Gastrointestinal Cancer, Barcelona, Spain

26/06/2014      Tolerance of raltitrexed when replacing a fluoropyrimidine in colorectal cancer. Poster, 16th World Congress on Gastrointestinal Cancer, Barcelona, Spain

27/06/2014      Cardiac toxicity with fluoropyrimidines in colorectal cancer. Poster, 16th World Congress on Gastrointestinal Cancer, Barcelona, Spain

26/06/2014      Ocular toxicities with oxaliplatin in colorectal cancer. Poster, 16th World Congress on Gastrointestinal Cancer, Barcelona, Spain

04/11/2013      Metastatic pancreatic cancer: is there a real hope? BIT’s Major Diseases Clinical Summit-2013, Warsaw, Poland. Speaker and chair of the session

Uña E. 2012 (June). Rectal Cancer: The Relevance of the Interval Between Chemoradiation (CRT) and Surgery. ESMO 14th World Congress on Gastrointestinal Cancer, Barcelona, Spain. Poster session.
Uña E. 2012 (June). Surveillance with serial serum carcinoembryonic levels detect colorectal cancer recurrences in patients who are initial nonsecretors. ESMO 14th World Congress on Gastrointestinal Cancer, Barcelona, Spain. Poster session.
Uña E. 2010 (June). Relevance of screening on the colorectal cancer population. ESMO Conference: Poster presented at 12th World Congress on Gastrointestinal Cancer. Ann Oncol 21, 2010 (suppl 6; abstr P0115).
Uña E. 2009 (June).Cost-effectiveness of follow-up strategies in colon cancer. ESMO Conference: Poster presented at 11th World Congress on Gastrointestinal Cancer. Ann Oncol 20, 2009 (suppl 7; abstr P0198).
Uña E, Bustamante R, Fernández L, Legido P, Juárez M, Robles J, Abril C, Herreros J, Toledano M, Ovejero J, Huidobro A, Bombín M, Ortiz de Solórzano J, Beltrán de Heredia J, López-Lara F. 2009 (June).Preoperative serum levels of CA 72.4, CEA, CA 19.9 in patients with gastric cancer. ESMO Conference: Poster presented at 11th World Congress on Gastrointestinal Cancer. Ann Oncol 20, 2009 (suppl 7; abstr P0243).
Uña E, Borau MJ, De la Torre A, Nieto J, López-Lara F. 2008 (June).Computed tomography (CT) in the preoperative staging of gastric cancer: does it work?. ESMO Conference: Poster presented at 10th World Congress on Gastrointestinal Cancer. Ann Oncol 19, 2008 (suppl 6; abstr P014).
Uña E, Fernández B, De la Torre A, Borau MJ, Nieto J, López-Lara F. 2007 (June). Predictive factors of lymph nodes metastasis in gastric cancer. ESMO Conference: Poster presented at 9th World Congress on Gastrointestinal Cancer. Ann Oncol 18, 2007 (suppl 7; abstr P0270).
Uña E, Fernández G. 2006 (September) Gastric cancer: Predictors of recurrence when the lymph node examination is inadequate. ESMO Conference: Poster presented at 9th World Congress on Gastrointestinal Cancer. Ann Oncol 17, 2006 (suppl 9; abstr 1107P).
Uña E, Fernández G. 2006 (September). Gastric cancer: Predictors of recurrence when the lymph node examination is inadequate. ESMO Conference: Poster presented at 9th World Congress on Gastrointestinal Cancer. Ann Oncol 17, 2006 (suppl 9; abstr 1107P).
Uña E. 2009 (March). Nutritional Status in patients with total gastrectomy for gastric cancer. ESMO Symposium on Cancer and Nutrition. Poster discussion PD-12.

 

SPANISH SOCIETY OF MEDICAL ONCOLOGY CONGRESS

 

Uña E, Alonso P, Perea C, López-Lara F. 2011 (October). Rectal Cancer: Relevance of interval duration between neoadjuvant therapy and surgery. XII Congress of Spanish Society of Medical Oncology: Oral Communication O-12.
Uña E, García Centeno R, Peral JI, García Lagarto E. 2011 (October). Her-2 status in a gastric cancer high risk population. XII Congress of Spanish Society of Medical Oncology: Oral Communication O-32.
Uña E. 2011 (October). Formation of oncology nursing staff as a new strategy of safety. XII Congress of Spanish Society of Medical Oncology: Oral Communication P-36.
Uña E. 2011 (October). Sleep disturbances in cancer survivors. XII Congress of Spanish Society of Medical Oncology: Poster P-50.
Uña E, Alonso P, Diezhandino P. 2011 (October). Indolent extravasation: a challenge. XII Congress of Spanish Society of Medical Oncology: Poster P-64.
Uña E. 2011 (October). Fatigue as a cause of sexual problems in breast cancer patients. XII Congress of Spanish Society of Medical Oncology: Poster P-188.
Uña E. 2011 (October). Retrospective study of the role of screening in colorectal cancer. XII Congress of Spanish Society of Medical Oncology: Poster P-325.
Uña E. 2011 (October). Value of CEA in followup of non-secretor colorectal cancers. XII Congress of Spanish Society of Medical Oncology: Poster P-348.
Uña E. 2011 (October).Colostomy complications in patients with colorectal cancer. XII Congress of Spanish Society of Medical Oncology: Poster P-344.
Uña E. 2011 (October).Subjective evaluation of XELOX toxicity in adjuvant colon cancer treatment. XII Congress of Spanish Society of Medical Oncology: Poster P-351.
Uña E. 2011 (October).Benefits of yoga in relieving fatigue in breast cancer survivors. XII Congress of Spanish Society of Medical Oncology: Book Communication L-24.
Uña E, López-Lara F. 2009 (October). Cost-effectiveness of two strategies of colon cancer follow-up. XII Congress of Spanish Society of Medical Oncology: Poster P-31.
Uña E. 2009 (October). Pilot study of the implementation of a clinical pathway (CP) in rectal cancer. XII Congress of Spanish Society of Medical Oncology: Poster P-33.
Uña E. 2009 (October).FLOX modified (m) in adjuvant colon cancer treatment. XII Congress of Spanish Society of Medical Oncology: Poster P-58.
Uña E. 2009 (October).Nutritional evaluation of gastric cancer patients after gastrectomy. Congress of Spanish Society of Medical Oncology: Poster P-88.
Uña E, Cuadrillero F, López-Lara F. 2009 (October).Implementation of standardized treatment protocols in an outpatient oncology unit. XII Congress of Spanish Society of Medical Oncology: Poster P-185.
Uña E, Diezhandino P, Nieto J, López-Lara F. 2009 (October). Lymphedema in breast cancer survivors. XII Congress of Spanish Society of Medical Oncology: Poster P-227.
Uña E, Fernández G. 2009 (October). Rentability of diagnostic studies in breast cancer. XII Congress of Spanish Society of Medical Oncology: Poster P-228.
Uña E, Ceballos A, Hortelano E, Perea C, López-Lara F. 2009 (October). Skin metastases: 32 cases. XII Congress of Spanish Society of Medical Oncology: Poster P-318.
Uña E, Salvador A, Fernández M. 2009 (October). Pilot study of electronic prescription of anticancer drugs. XII Congress of Spanish Society of Medical Oncology: Book communication L-46.
Uña E, Bustamante R, Montenegro MA, Núñez H, Ceballos A, Hortelano E, Perea C, López-Lara F. 2009 (October). Prognostic utility of preoperative serum levels of CA 72.4 and CEA/CA 19.9 in gastric cancer. XII Congress of Spanish Society of Medical Oncology: Book communication L-71.
Uña E, Fernández G, Borau MJ, López-Lara F. 2007 (October). Computed tomography in preoperative diagnosis of Gastric Cancer. XI Congress of Spanish Society of Medical Oncology: Poster P-318.
Uña E, Fernández G. 2007 (October). Predictive factors of recurrence in resected gastric cancer. XI Congress of Spanish Society of Medical Oncology: Poster P-324.
Uña E, De la Torre A, Fernández G, López-Lara F. 2007 (October). Retrospective study of breast cancer patients in our region. XI Congress of Spanish Society of Medical Oncology: Book communication L-8.
Uña E, Nieto J. 2007 (October). Impact of neoadjuvant treatment in the number of lymph nodes analysed in rectal cancer. XI Congress of Spanish Society of Medical Oncology: Book communication L-67.
Uña E, Fernández G, Mareque B, De la Torre A, López-Lara F. 2007 (October). Gastric cancer: Predictive factors of recurrence in T3 tumors with insufficient number of lymph nodes analysed. XI Congress of Spanish Society of Medical Oncology: Poster presented P-321.
Soto D, Uña E, Ceballos A, Borau MJ, De la Torre A, Valle ML, Nieto J, López-Lara F. 2007 (October). Quality of life questionnaires in terminal cancer patients. XI Congress of Spanish Society of Medical Oncology: Book communication L-82.

 

ISGIO CONFERENCES

 

Uña E. 2010 (September). Colorectal cancer population: the role of screening. (Abstract 1019). 7th Annual Meeting of International Society of Gastrointestinal Oncology. Poster session.
Uña E, López-Lara F. 2009 (October) Retrospective Assessment of an Alternative Adjuvant Treatment of Colon Cancer: Oxaliplatin Plus Weekly Bolus 5-Fluorouracil/ Leucovorin. (Abstract 0943). 6th Annual Meeting of International Society of Gastrointestinal Oncology. Poster session.
Uña E, Jiménez I. 2009 (October). Preoperative Computed Tomography in Gastric Cancer: Does it work? (Abstract 0955). 6th Annual Meeting of International Society of Gastrointestinal Oncology. Poster session.
Uña E. 2009 (October). Nutritional Status after total Gastrectomy for gastric cancer. (Abstract 0956). 6th Annual Meeting of International Society of Gastrointestinal Oncology. Poster session.

OTHER CONGRESSES ( including Clinical Management Congresses)

 

Uña E. 2010 (October). Fatigue as a Cause of Sexual Problems in Breast Cancer Patients. Presented as poster at 2nd International Cancer Fatigue Symposium. Montreal, Quebec, (P041, page 81. Current Oncology 2010;17(5):81).
Bustamante R, Aguirre B, Crespo J, Arana J, Uña E, Muñoz F. 2010 (October). Diagnostic usefulness of Pro-GRP and NSE in small cell lung cancer. IV National Congress of Laboratory Analysis. Poster session 861.
Cuadrillero F, Uña E. 2010 (October). Caring protocol in prostatic radiotherapy. XXV Oncology Nursing Conferences. Poster.
Uña E, López Lara F. 2010 (April). Pilot study of the implementation of a clinical pathway in rectal cancer. The International Forum on Quality & Safety in Healthcare. Poster.
Uña E. 2009 (July). A different alternative as adjuvant treatment in colon cancer. XXI Congress of Colorectal Cancer. Poster session.
Uña E. 2009 (November). Computed tomography in preoperative gastric cancer: is it useful? Poster presentation. P1586. GASTRO UEGW/WCOG London.
Uña E. 2009 (November). Cost-effectiveness of follow-up strategies in colon cancer. Poster presentation. P0425. GASTRO UEGW/WCOG London.
Uña E. 2009 (June). Nutritional status in patients with total gastrectomy for gastric cancer. X Congress of Oncology La Habana. Poster session.
Uña E. 2009 (June). Tomography in the preoperative staging in gastric cancer: does it work?. X Congress of Oncology La Habana. Poster session.
Uña E. 2009 (August). Medular thyroid cancer and sunitinib: A case report. World Congress on Thyroid Cancer. Vancouver, Canadá. Poster session.
Uña E. 2009 (June). Lymphedema in breast cancer survivors. International Conference on Breast Cancer, Madrid (Spain). Poster session.
Uña E. 2008 (February). Screening for metastatic disease in early stage breast cancer”. 6ª European Conference on Breast Cancer. Poster session.
Cuadrillero F, Uña E. 2008 (April). Clinical Management and Oncology nursing staff. National Conference of Nursing Supervision. Poster session.
Uña E. 2007 (June). Gastric Cancer: predictors of recurrence in T3 with inadequate node examination. III International Congress of Gastrointestinal Oncology, Crete. Poster session.
Uña E. 2007 (June). Gastric Cancer: tumoral markers as predicitive factors of recurrence. III International Congress of Gastrointestinal Oncology Crete. Poster session.
Soto D, Uña E, Cebayos A.2007 (October). Quality of life questionnaires in terminal cancer patients. National Congress of Spanish Society of Radiotherapy Oncology. Poster session.
Uña E, Nieto J. 2007 (October). Impact of neoadjuvant treatment in the number of lymph nodes analysed in rectal cancer. National Congress of Spanish Society of Radiotherapy Oncology. Poster session.
Uña E, Fernández G. 2007 (October). Gastric cancer: Predictive factors of recurrence in T3 tumors with insufficient number of lymph nodes analysed. National Congress of Spanish Society of Radiotherapy Oncology Poster session.
Uña E. 2007 (October). Computed tomography in preoperative diagnosis of Gastric Cancer. National Congress of Spanish Society of Radiotherapy Oncology Poster session.

 

 

HOBBIES: Sports (cycling, boxing, fitness...), writting (published Mr Martinez's follies), reading...

 

What I think of the idea behind WebmedCentral:


I think it is a very interesting idea because authors could have their work published quicker than with conventional ways and this is also a way to inform the rest of the scientific community about something considered relevant but may be very difficult to publish it in  a conventional journal. All of us as authors have had these kind of problems several times. I think the new idea you have had is very good because the rapidity of publication of new ideas, the facility to know about all these new publications as well as the facility to make a comment to emphasize the authors´ ideas or to critic their article by the introduction of new concepts they forgot about... 

I am really impressed with this new idea to publish